BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 27825428)

  • 1. Diagnostic and Therapeutic Strategies for Prostate Cancer.
    Nguyen-Nielsen M; Borre M
    Semin Nucl Med; 2016 Nov; 46(6):484-490. PubMed ID: 27825428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expectant management for men with early stage prostate cancer.
    Filson CP; Marks LS; Litwin MS
    CA Cancer J Clin; 2015; 65(4):265-82. PubMed ID: 25958817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia.
    Dantanarayana ND; Hossack T; Cozzi P; Brooks A; Lau H; Delprado W; Patel MI
    BMC Urol; 2015 Dec; 15():124. PubMed ID: 26715039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
    Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K
    Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease recurrence after radical prostatectomy. Contemporary diagnostic and therapeutical strategies.
    Augustin H; Hammerer PG
    Minerva Urol Nefrol; 2003 Dec; 55(4):251-61. PubMed ID: 14765017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for early detection of prostate cancer (first experience in Israel)].
    Neheman A; Shotland Y; Metz Y; Stein A
    Harefuah; 2001 Jan; 140(1):4-10, 88, 87. PubMed ID: 11242898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early detection or screening in the prevention of prostate cancer?].
    Brenes Bermúdez FJ; Alcántara Montero A
    Semergen; 2017 Mar; 43(2):100-108. PubMed ID: 26960257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
    Tawfik A
    Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative management of prostate cancer in the prostate specific antigen era: the incidence and time course of subsequent therapy.
    Zietman AL; Thakral H; Wilson L; Schellhammer P
    J Urol; 2001 Nov; 166(5):1702-6. PubMed ID: 11586206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
    Haines IE; Gabor Miklos GL
    J Natl Cancer Inst; 2013 Oct; 105(20):1534-9. PubMed ID: 24092918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial. PSA screening and low risk prostate cancer, what's going on? are we shooting the messenger?
    Martínez-Salamanca JI
    Arch Esp Urol; 2012 Mar; 65(2):209-14. PubMed ID: 22414449
    [No Abstract]   [Full Text] [Related]  

  • 16. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.
    Roemeling S; Roobol MJ; Postma R; Gosselaar C; van der Kwast TH; Bangma CH; Schröder FH
    Eur Urol; 2006 Sep; 50(3):475-82. PubMed ID: 16713065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the diagnosis and treatment of prostate cancer.
    Kirby R
    Practitioner; 2010 Feb; 254(1726):21, 23-4, 2. PubMed ID: 20307026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, management and screening of early localised prostate cancer.
    Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
    Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novelties in diagnostics and treatment of prostate cancer].
    Riesz P; Nyírádi P
    Orv Hetil; 2016 Mar; 157(11):410-4. PubMed ID: 26947089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of prostate cancer.
    Naitoh J; Zeiner RL; Dekernion JB
    Am Fam Physician; 1998 Apr; 57(7):1531-9, 1541-2, 1545-7. PubMed ID: 9556643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.